Related Experiment Video
Updated: Jun 24, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi
Trijn Israëls1, Marianne D van de Wetering, Peter Hesseling
1Department of Paediatrics, College of Medicine, University of Malawi, Blantyre, Malawi. trijnisraels@hotmail.com
Insights
Malnutrition in children with Burkitt lymphoma significantly increases the risk of severe neutropenia and treatment-related deaths. Treatment protocols must adapt to nutritional status to improve outcomes in these vulnerable pediatric cancer patients.
Area of Science:
- Pediatric Oncology
- Infectious Disease Management
- Global Health
Background:
- Infection in neutropenic children is a critical factor in cancer treatment morbidity and mortality.
- Malnutrition is prevalent in children with cancer in developing countries, impacting treatment.
- Burkitt lymphoma treatment in Malawi uses a local protocol with limited toxicity.
Purpose of the Study:
- To evaluate the incidence and outcomes of febrile neutropenia during Burkitt lymphoma treatment.
- To assess the association between malnutrition at diagnosis and febrile neutropenia.
- To determine treatment-related mortality in this pediatric cohort.
Main Methods:
- Documented nutritional status (Arm Muscle Area) of pediatric Burkitt lymphoma patients.
- Monitored febrile and/or neutropenic episodes and antibiotic use.
- Recorded short-term outcomes, including treatment-related deaths.
Main Results:
- 69% of patients presented with acute malnutrition (Arm Muscle Area < 5th percentile).
- Malnutrition strongly correlated with profound neutropenia (OR 12, P=0.012), even after controlling for confounders.
- All cases of profound neutropenia, prolonged neutropenia, and treatment-related deaths occurred in malnourished patients.
Conclusions:
- Acute malnutrition at diagnosis is significantly linked to increased treatment-related profound neutropenia.
- Chemotherapy intensity should be adjusted based on nutritional status and supportive care.
- The local Burkitt lymphoma treatment protocol in Malawi has a 5% treatment-related mortality rate.
Background:
Infection in neutropenic children is a major cause of morbidity and mortality in children treated for cancer. In developing countries, children with cancer are often malnourished at diagnosis. In Blantyre, Malawi, children with Burkitt lymphoma are treated with a local protocol with limited toxicity. The aim of this study was to evaluate the incidence and outcome of febrile neutropenia during this treatment and the association with malnutrition at diagnosis.
Methods:
We documented nutritional status, febrile and/or neutropenic episodes, antibiotic therapy and short term outcome of all children with Burkitt lymphoma treated according to the local protocol and admitted from January 2007 to March 2008.
Results:
Fifty eight (69%) of 84 patients were acutely malnourished at diagnosis with an arm muscle area (AMA) below the 5(th) percentile. Malnutrition at diagnosis was associated with a significantly higher rate of profound neutropenia. This association remained significant (OR 12; 95% C.I. 1.5 - infinitely; P = 0.012) after control for clinical stage of disease, bone marrow involvement and HIV infection which are possible confounders. All patients with profound neutropenia, prolonged neutropenia and treatment related deaths were malnourished at diagnosis. Four (4.9%) of 81 patients died of treatment related causes; three of them due to a Gram negative septicaemia.
Conclusion:
Acute malnutrition at diagnosis is associated with significantly more treatment related profound neutropenia. The intensity of chemotherapeutic regimens has to be adapted to the level of available supportive care and patients' nutritional status and tolerance to avoid unacceptable morbidity and mortality. This local treatment protocol for Burkitt lymphoma has a treatment related mortality of 5% in patients in Malawi.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Fungal Phylum Microsporidia